Results 181 to 190 of about 616,145 (212)
Some of the next articles are maybe not open access.
[Diagnostics of non-small cell lung carcinoma].
Duodecim; laaketieteellinen aikakauskirja, 2014ALK inhibitor therapy is individual cancer treatment, in which the targeted drug therapy is directed to a patient group that is likely to benefit from the therapy. The detection in the tumor of ALK gene (anaplastic lymphoma kinase) rearrangement is a prerequisite for the ALK inhibitor therapy for non-small cell lung carcinoma.
Kaisa, Salmenkivi, Aija, Knuuttila
openaire +1 more source
Non-small cell lung carcinoma. Clinical case
Filin’s Clinical endoscopyIn 2020, 2.2 million new cases of lung cancer were reported. The main form of lung cancer is non-small cell carcinoma (85%). Non-small cell lung cancer has 3 subtypes: adenocarcinoma, large cell and squamous cell carcinoma. Squamous cell lung cancer occurs in 20-40% of all lung cancers.
openaire +1 more source
[Treatment of non-small cell lung carcinoma].
La Revue du praticien, 2003Non small cell lung cancer is the most common histologic type (80 to 85%) with an incidence of 20 to 25,000 cases by year in France. Almost fifty per cent of cases are stage IV disease, at diagnosis and the treatment is palliative by chemotherapy. Locally advanced disease is treated by an association of chemo and radiotherapy.
openaire +1 more source